WHO Raises Concern Over Acute Lack of Obesity Injections
Less than 10% of patients who could benefit from weight-loss injections such as Wegovy can access them, caution the World Health Organization as it releases its initial advice on the medications.
With more than one billion individuals worldwide currently classified as obese, it is urging more widespread and fairer access to these injectable treatments.
Per forecasts, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"Our latest guidelines recognises that excess weight is a lifelong illness that can be addressed with thorough and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and supply-chain constraints are key barriers to universal access to the treatments that can assist patients in reducing significant body mass, says the organization.
Skinny Jab Shortage
Even under the present best projected scenario, the manufacturing of GLP-1 therapies would only suffice for about 100 million people – under 10% of the global need, according to the WHO.
The recommendation urges countries and companies to expand availability, by strategies such as voluntary licensing.
The intellectual property rights on semaglutide – the core component of Novo Nordisk's Wegovy – is set to lapse in a number of nations in 2026.
The Way Weight-Loss Injections Work
These medications replicate a biological compound to reduce digestion speed, curb appetite and boost satiety so users eat less.
Patients usually start to lose weight in the initial weeks of beginning the regular doses.
Research indicates users may regain a significant portion after a year of discontinuing the medication, when their usual appetite come back.
Being carrying excess weight elevates your risk for experiencing diseases, like diabetes, heart disease, stroke, and specific cancers.
Obesity affects individuals in countries worldwide and was linked to over three and a half million deaths worldwide in 2024, according to the health agency.
